Joining together: Group theory and group skills DW Johnson, FP Johnson Prentice-Hall, Inc, 1991 | 7443 | 1991 |
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ... N Engl J Med, 2019 | 5179 | 2019 |
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo … C Baigent, MJ Landray, C Reith, J Emberson, DC Wheeler, C Tomson, ... The Lancet 377 (9784), 2181-2192, 2011 | 2961 | 2011 |
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease MA Pfeffer, EA Burdmann, CY Chen, ME Cooper, D De Zeeuw, ... New England Journal of Medicine 361 (21), 2019-2032, 2009 | 2449 | 2009 |
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis BC Fellström, AG Jardine, RE Schmieder, H Holdaas, K Bannister, ... New England Journal of Medicine 360 (14), 1395-1407, 2009 | 2322 | 2009 |
Cooperation and the use of technology DW Johnson, RT Johnson Handbook of research on educational communications and technology, 777-803, 2013 | 1387 | 2013 |
Peritoneal dialysis-related infections recommendations: 2010 update PKT Li, CC Szeto, B Piraino, J Bernardini, AE Figueiredo, A Gupta, ... Peritoneal dialysis international 30 (4), 393-423, 2010 | 1259 | 2010 |
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. L Philip, CC Szeto, B Piraino, J de Arteaga, S Fan, A Figueiredo, D Fish, ... Perit Dial Int 36 (5), 481-508, 2016 | 1148 | 2016 |
A randomized, controlled trial of early versus late initiation of dialysis BA Cooper, P Branley, L Bulfone, JF Collins, JC Craig, MB Fraenkel, ... New England Journal of Medicine 363 (7), 609-619, 2010 | 1029 | 2010 |
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy A Levin, M Tonelli, J Bonventre, J Coresh, JA Donner, AB Fogo, CS Fox, ... The Lancet 390 (10105), 1888-1917, 2017 | 921 | 2017 |
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies S Palmer, M Vecchio, JC Craig, M Tonelli, DW Johnson, A Nicolucci, ... Kidney international 84 (1), 179-191, 2013 | 915 | 2013 |
Oxidative stress, anti‐oxidant therapies and chronic kidney disease DM Small, JS Coombes, N Bennett, DW Johnson, GC Gobe Nephrology 17 (4), 311-321, 2012 | 626 | 2012 |
Changes in the worldwide epidemiology of peritoneal dialysis PKT Li, KM Chow, MWM Van de Luijtgaarden, DW Johnson, KJ Jager, ... Nature Reviews Nephrology 13 (2), 90-103, 2017 | 553 | 2017 |
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials GFM Strippoli, SD Navaneethan, DW Johnson, V Perkovic, F Pellegrini, ... Bmj 336 (7645), 645-651, 2008 | 544 | 2008 |
The current state of peritoneal dialysis R Mehrotra, O Devuyst, SJ Davies, DW Johnson Journal of the American Society of Nephrology 27 (11), 3238-3252, 2016 | 541 | 2016 |
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta … SC Palmer, B Tendal, RA Mustafa, PO Vandvik, S Li, Q Hao, D Tunnicliffe, ... Bmj 372, 2021 | 537 | 2021 |
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. SD Navaneethan, F Pansini, V Perkovic, C Manno, F Pellegrini, ... The Cochrane database of systematic reviews, CD007784-CD007784, 2009 | 515* | 2009 |
Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis SC Palmer, D Mavridis, A Nicolucci, DW Johnson, M Tonelli, JC Craig, ... Jama 316 (3), 313-324, 2016 | 493 | 2016 |
Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial J Lv, H Zhang, MG Wong, MJ Jardine, M Hladunewich, V Jha, ... Jama 318 (5), 432-442, 2017 | 483 | 2017 |
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease SC Palmer, SD Navaneethan, JC Craig, DW Johnson, M Tonelli, AX Garg, ... Annals of internal medicine 153 (1), 23-33, 2010 | 466 | 2010 |